Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 1
2011 1
2012 1
2013 3
2014 5
2015 8
2016 3
2017 10
2018 9
2019 5
2020 7
2021 8
2022 7
2023 5
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials.
Palmer SC, Tendal B, Mustafa RA, Vandvik PO, Li S, Hao Q, Tunnicliffe D, Ruospo M, Natale P, Saglimbene V, Nicolucci A, Johnson DW, Tonelli M, Rossi MC, Badve SV, Cho Y, Nadeau-Fredette AC, Burke M, Faruque LI, Lloyd A, Ahmad N, Liu Y, Tiv S, Millard T, Gagliardi L, Kolanu N, Barmanray RD, McMorrow R, Raygoza Cortez AK, White H, Chen X, Zhou X, Liu J, Rodríguez AF, González-Colmenero AD, Wang Y, Li L, Sutanto S, Solis RC, Díaz González-Colmenero F, Rodriguez-Gutierrez R, Walsh M, Guyatt G, Strippoli GFM. Palmer SC, et al. Among authors: rossi mc. BMJ. 2021 Jan 13;372:m4573. doi: 10.1136/bmj.m4573. BMJ. 2021. PMID: 33441402 Free PMC article.
Real world effectiveness of subcutaneous semaglutide in type 2 diabetes: A retrospective, cohort study (Sema-MiDiab01).
Berra CC, Rossi MC, Mirani M, Ceccarelli Ceccarelli D, Romano C, Sassi L, Peretti E, Favacchio G, Pastore I, Folini L, Graziano G, Lunati ME, Solerte SB, Fiorina P. Berra CC, et al. Among authors: rossi mc. Front Endocrinol (Lausanne). 2023 Jan 18;13:1099451. doi: 10.3389/fendo.2022.1099451. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36743930 Free PMC article.
Urban diabetes: the case of the metropolitan area of Rome.
Nicolucci A, Rossi MC, Vaccaro K, Crialesi R, Rossetti S, Da Empoli S, Corsaro L, Morviducci L, Baroni MG, Frontoni S, Dotta F. Nicolucci A, et al. Among authors: rossi mc. Acta Biomed. 2019 May 23;90(2):209-214. doi: 10.23750/abm.v90i2.8345. Acta Biomed. 2019. PMID: 31124997 Free PMC article. Review.
Treatment intensification following glucagon-like peptide-1 receptor agonist treatment in type 2 diabetes: The RESTORE-G real-world study.
Candido R, Nicolucci A, Larosa M, Rossi MC, Napoli R; RESTORE-G (Retrospective analysis on the therapeutic approaches after GLP-1 RA treatment in type 2 diabetes patients) Study Group. Candido R, et al. Among authors: rossi mc. Nutr Metab Cardiovasc Dis. 2023 Nov;33(11):2294-2305. doi: 10.1016/j.numecd.2023.07.025. Epub 2023 Jul 22. Nutr Metab Cardiovasc Dis. 2023. PMID: 37679243 Free article.
Type 2 Diabetes and Cardiovascular Risk in Women 2016.
Kautzky-Willer A, Baggio G, Rossi MC, Lapolla A, Russo GT. Kautzky-Willer A, et al. Among authors: rossi mc. Int J Endocrinol. 2017;2017:6905697. doi: 10.1155/2017/6905697. Epub 2017 Jul 4. Int J Endocrinol. 2017. PMID: 28744311 Free PMC article. No abstract available.
Treatment intensification following glucagon-like peptide-1 receptor agonist in type 2 diabetes: Comparative effectiveness analyses between free vs. fixed combination of GLP-1 RA and basal insulin. RESTORE-G real-world study.
Candido R, Nicolucci A, Larosa M, Rossi MC, Napoli R; RESTORE-G (Retrospective analysis on the therapeutic approaches after GLP-1 RA treatment in type 2 diabetes patients) Study Group. Candido R, et al. Among authors: rossi mc. Nutr Metab Cardiovasc Dis. 2024 Aug;34(8):1846-1853. doi: 10.1016/j.numecd.2024.03.023. Epub 2024 Mar 23. Nutr Metab Cardiovasc Dis. 2024. PMID: 38693036 Free article.
The social burden of hypoglycemia in the elderly.
Nicolucci A, Pintaudi B, Rossi MC, Messina R, Dotta F, Frontoni S, Caputo S, Lauro R. Nicolucci A, et al. Among authors: rossi mc. Acta Diabetol. 2015 Aug;52(4):677-85. doi: 10.1007/s00592-015-0717-0. Epub 2015 Feb 8. Acta Diabetol. 2015. PMID: 25663036
Osteopathic Manipulative Treatment in Neonatal Intensive Care Units.
Cicchitti L, Di Lelio A, Barlafante G, Cozzolino V, Di Valerio S, Fusilli P, Lucisano G, Renzetti C, Verzella M, Rossi MC. Cicchitti L, et al. Among authors: rossi mc. Med Sci (Basel). 2020 Jun 24;8(2):24. doi: 10.3390/medsci8020024. Med Sci (Basel). 2020. PMID: 32599697 Free PMC article.
Prediction of complications of type 2 Diabetes: A Machine learning approach.
Nicolucci A, Romeo L, Bernardini M, Vespasiani M, Rossi MC, Petrelli M, Ceriello A, Di Bartolo P, Frontoni E, Vespasiani G. Nicolucci A, et al. Among authors: rossi mc. Diabetes Res Clin Pract. 2022 Aug;190:110013. doi: 10.1016/j.diabres.2022.110013. Epub 2022 Jul 21. Diabetes Res Clin Pract. 2022. PMID: 35870573
69 results